Pivotal Results of the Phase 3 PROTECT Trial of Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Immunoglobulin A Nephropathy (IgAN)

被引：0
|
作者：
Busch, Martin [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 3, Jena, Germany
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P21-07
引用
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [1] SPARSENTAN (SPAR) SHOWS CLINICALLY MEANINGFUL TREATMENT EFFECTS VS IRBESARTAN (IRB) IN PATIENTS WITH IGA NEPHROPATHY (IGAN) IN THE PHASE 3 PROTECT TRIAL
    Rovin, Brad
    Barratt, Jonathan
    Murphy, Edward
    Geletka, Rob
    Komers, Radko
    Perkovic, Vlado
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S114 - S114
  • [2] SPARSENTAN (SPAR) VS IRBESARTAN (IRB) IN PATIENTS (PTS) WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS): RESULTS FROM THE DUPLEX TRIAL
    Rheault, Michelle
    Trachtman, Howard
    Murphy, Edward
    Komers, Radko
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S123 - S123
  • [3] PROTEINURIA REDUCTION WITH SPARSENTAN IN IMMUNOGLOBULIN A NEPHROPATHY (IGAN): PROTECT STUDY INTERIM RESULTS
    Radhakrishnan, Jai
    Wong, Muh Geot
    Heerspink, Hiddo J. L.
    Komers, Radko
    Prasad, Andy
    Mercer, Alex
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S97 - S97
  • [4] SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IGA NEPHROPATHY (IGAN): FINDINGS FROM THE SPARTAN TRIAL
    Cheung, Chee Kay
    Nloody, Stephanie
    Dhaun, Neeraj
    Griffin, Sian
    Howson, Alexandra
    Komers, Radko
    Mercer, Alex
    Sayer, Matthew
    Sinha, Smeeta
    Willcocks, Lisa
    Barratt, Jonathan
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S117 - S117
  • [5] Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
    Rovin, Brad H.
    Barratt, Jonathan
    Heerspink, Hiddo J. L.
    Alpers, Charles E.
    Bieler, Stewart
    Chae, Dong-Wan
    Diva, Ulysses A.
    Floege, Juergen
    Gesualdo, Loreto
    Inrig, Jula K.
    Kohan, Donald E.
    Komers, Radko
    Kooienga, Laura Ann
    Lafayette, Richard
    Maes, Bart
    Malecki, Robert
    Mercer, Alex
    Noronha, Irene L.
    Oh, Se Won
    Peh, Chen Au
    Praga, Manuel
    Preciado, Priscila
    Radhakrishnan, Jai
    Rheault, Michelle N.
    Rote, William E.
    Tang, Sydney C. W.
    Tesar, Vladimir
    Trachtman, Howard
    Trimarchi, Hernan
    Tumlin, James A.
    Wong, Muh Geot
    Perkovic, Vlado
    [J]. LANCET, 2023, 402 (10417): : 2077 - 2090
  • [6] BASELINE CHARACTERISTICS OF ADULTS ENROLLED IN THE ONGOING PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL TRIAL OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY (PROTECT)
    Wong, Muh
    Barratt, Jonathan
    Komers, Radko
    Mercer, Alex
    Rosenberg, Noah
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I142 - I144
  • [7] Phase 3 trial results bring hope for patients with IgA nephropathy
    Haraldsson, Boerje
    [J]. LANCET, 2023, 402 (10405): : 827 - 829
  • [8] Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study
    Perkovic, Vlado
    Kollins, Dmitrij
    Papachristofi, Olympia
    Hach, Thomas
    Jacinto-Sanders, Severina
    Merkel, Tobias
    Renfurm, Ronny
    Rizk, Dana V.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I255 - I256
  • [9] RESULTS OF A RANDOMIZED PHASE "'TRIAL IN 366 PATIENTS ON THE EFFECT OF DEXPANTHENOL VS. WATER MOUTH WASHES ON ORAL MUCOSITIS
    Doerr, W.
    Doerr, E.
    Herrmann, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S51 - S52
  • [10] PENTOXIFYLLINE (PTX) REDUCES THE RISK OF COMPLICATIONS IN PATIENTS WITH ADVANCED CIRRHOSIS. ANALYSIS OF THE RESULTS OF A PIVOTAL PHASE 3 TRIAL
    Lebrec, D.
    Thabut, D.
    Oberti, F.
    Perarnau, J. -M.
    Condat, B.
    Barraud, H.
    Saliba, F.
    Carbonell, N.
    Renard, P.
    Ramond, M. -J.
    Moreau, R.
    Poynard, T.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S378 - S378
12345